Literature DB >> 8389799

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay.

L Stuyver1, R Rossau, A Wyseur, M Duhamel, B Vanderborght, H Van Heuverswyn, G Maertens.   

Abstract

A reverse-hybridization assay, the line probe assay (LiPA), based on variations found in the 5' untranslated regions of the different hepatitis C virus (HCV) genotypes was developed, permitting simple and fast determination of four HCV genotypes and their subtypes. Using this assay, 61 PCR-positive Brazilian HCV sera were typed. Of the sera, 33% had a type 1 HCV infection, 38% had type 1b (related to HCV-J), 1.5% had type 2a (related to HC-J6), 24.5% had type 3 (related to E-b1 and HCV-T), and 3% of the sera were co-infected. This assay format was further evaluated using 13 sera from Belgium and the Netherlands, and all of these could be classified. Two pools of Japanese sera were classified as either type 2a or were co-infected with types 1b and 2a, but no type 2b sequences were detected. Another eight PCR-positive sera were obtained from Burundi and Gabon. The sequence of the 5' untranslated region of these African viruses was strongly divergent from the three previously described types. Therefore, these isolates were tentatively classified as type 4. These and some of the other non-type 1 sera often demonstrated weaker reactivities than type 1 isolates in currently used second generation antibody confirmation assays.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389799     DOI: 10.1099/0022-1317-74-6-1093

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  136 in total

1.  Hepatitis C virus serotypes and sources of infection in patients with HCV-related chronic liver disease from one geographical area in southeast Italy.

Authors:  P Dentico; N Curatolo; R Sacco; M De Luca; A Volpe; C Ranieri; C Genchi; L Petracca; R Buongiorno
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

2.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

Review 3.  Laboratory assays for diagnosis and management of hepatitis C virus infection.

Authors:  Sandra S Richter
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

4.  Recent advances in laboratory diagnosis of hepatitis C virus infection.

Authors:  R Chaudhary
Journal:  Can J Infect Dis       Date:  1994-11

5.  Prevalence of HBV genotypes among Egyptian hepatitis patients.

Authors:  Iman A El Aziz Khaled; Ola M Mahmoud; Abeya F Saleh; Emad E Bioumie
Journal:  Mol Biol Rep       Date:  2010-12-23       Impact factor: 2.316

6.  Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.

Authors:  G Missale; R Bertoni; V Lamonaca; A Valli; M Massari; C Mori; M G Rumi; M Houghton; F Fiaccadori; C Ferrari
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

7.  Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin.

Authors:  Jeanette J McCarthy; Josephine H Li; Alexander Thompson; Sunil Suchindran; Xiang Qian Lao; Keyur Patel; Hans L Tillmann; Andrew J Muir; John G McHutchison
Journal:  Gastroenterology       Date:  2010-02-19       Impact factor: 22.682

8.  Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns.

Authors:  J M Pawlotsky; F Roudot-Thoraval; C Pellet; P Aumont; F Darthuy; J Remire; J Duval; D Dhumeaux
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

9.  Analysis of the core and E1 envelope region sequences of a novel variant of hepatitis C virus obtained in Indonesia.

Authors:  H Hotta; H Doi; T Hayashi; M Purwanta; W Soemarto; M Mizokami; K Ohba; M Homma
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology.

Authors:  J Detmer; R Lagier; J Flynn; C Zayati; J Kolberg; M Collins; M Urdea; R Sánchez-Pescador
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.